These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 38949638)

  • 1. High burden of viruses and bacterial pathobionts drives heightened nasal innate immunity in children.
    Watkins TA; Green AB; Amat JAR; Cheemarla NR; Hänsel K; Lozano R; Dudgeon SN; Germain G; Landry ML; Schulz WL; Foxman EF
    J Exp Med; 2024 Sep; 221(9):. PubMed ID: 38949638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human Nasal and Lung Tissues Infected
    Alfi O; Yakirevitch A; Wald O; Wandel O; Izhar U; Oiknine-Djian E; Nevo Y; Elgavish S; Dagan E; Madgar O; Feinmesser G; Pikarsky E; Bronstein M; Vorontsov O; Jonas W; Ives J; Walter J; Zakay-Rones Z; Oberbaum M; Panet A; Wolf DG
    J Virol; 2021 Jun; 95(14):e0013021. PubMed ID: 33893170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age-related Differences in the Nasal Mucosal Immune Response to SARS-CoV-2.
    Koch CM; Prigge AD; Anekalla KR; Shukla A; Do Umehara HC; Setar L; Chavez J; Abdala-Valencia H; Politanska Y; Markov NS; Hahn GR; Heald-Sargent T; Sanchez-Pinto LN; Muller WJ; Singer BD; Misharin AV; Ridge KM; Coates BM
    Am J Respir Cell Mol Biol; 2022 Feb; 66(2):206-222. PubMed ID: 34731594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age-Related Expression of IFN-λ1
    Gilbert C; Lefeuvre C; Preisser L; Pivert A; Soleti R; Blanchard S; Delneste Y; Ducancelle A; Couez D; Jeannin P
    Front Immunol; 2021; 12():750279. PubMed ID: 34858406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An enhanced IL17 and muted type I interferon nasal epithelial cell state characterizes severe COVID-19 with fungal coinfection.
    Ziegler CGK; Owings AH; Galeas-Pena M; Kazer SW; Miao VN; Navia AW; Tang Y; Bromley JD; Lotfy P; Sloan M; Laird H; Williams HB; George M; Drake RS; Pride Y; Abraham GE; Senitko M; Robinson TO; Diamond G; Lionakis MS; Shalek AK; Ordovas-Montanes J; Horwitz BH; Glover SC
    Microbiol Spectr; 2024 Jun; 12(6):e0351623. PubMed ID: 38687064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural mucosal barriers and COVID-19 in children.
    Pierce CA; Sy S; Galen B; Goldstein DY; Orner E; Keller MJ; Herold KC; Herold BC
    JCI Insight; 2021 May; 6(9):. PubMed ID: 33822777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS-CoV-2 innate effector associations and viral load in early nasopharyngeal infection.
    Liou TG; Adler FR; Cahill BC; Cox DR; Cox JE; Grant GJ; Hanson KE; Hartsell SC; Hatton ND; Helms MN; Jensen JL; Kartsonaki C; Li Y; Leung DT; Marvin JE; Middleton EA; Osburn-Staker SM; Packer KA; Shakir SM; Sturrock AB; Tardif KD; Warren KJ; Waddoups LJ; Weaver LJ; Zimmerman E; Paine R
    Physiol Rep; 2021 Feb; 9(4):e14761. PubMed ID: 33625796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nasal host response-based screening for undiagnosed respiratory viruses: a pathogen surveillance and detection study.
    Cheemarla NR; Hanron A; Fauver JR; Bishai J; Watkins TA; Brito AF; Zhao D; Alpert T; Vogels CBF; Ko AI; Schulz WL; Landry ML; Grubaugh ND; van Dijk D; Foxman EF
    Lancet Microbe; 2023 Jan; 4(1):e38-e46. PubMed ID: 36586415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal Analysis of Inflammatory Response to SARS-CoV-2 in the Upper Respiratory Tract Reveals an Association with Viral Load, Independent of Symptoms.
    Vu DL; Martinez-Murillo P; Pigny F; Vono M; Meyer B; Eberhardt CS; Lemeille S; Von Dach E; Blanchard-Rohner G; Eckerle I; Huttner A; Siegrist CA; Kaiser L; Didierlaurent AM
    J Clin Immunol; 2021 Nov; 41(8):1723-1732. PubMed ID: 34581925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mucosal Gene Expression in Response to SARS-CoV-2 Is Associated with Viral Load.
    Rajagopala SV; Strickland BA; Pakala SB; Kimura KS; Shilts MH; Rosas-Salazar C; Brown HM; Freeman MH; Wessinger BC; Gupta V; Phillips E; Mallal SA; Turner JH; Das SR
    J Virol; 2023 Feb; 97(2):e0147822. PubMed ID: 36656015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upper airway gene expression reveals suppressed immune responses to SARS-CoV-2 compared with other respiratory viruses.
    Mick E; Kamm J; Pisco AO; Ratnasiri K; Babik JM; Castañeda G; DeRisi JL; Detweiler AM; Hao SL; Kangelaris KN; Kumar GR; Li LM; Mann SA; Neff N; Prasad PA; Serpa PH; Shah SJ; Spottiswoode N; Tan M; Calfee CS; Christenson SA; Kistler A; Langelier C
    Nat Commun; 2020 Nov; 11(1):5854. PubMed ID: 33203890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nasal commensal Staphylococcus epidermidis enhances interferon-λ-dependent immunity against influenza virus.
    Kim HJ; Jo A; Jeon YJ; An S; Lee KM; Yoon SS; Choi JY
    Microbiome; 2019 May; 7(1):80. PubMed ID: 31146794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Robust innate responses to SARS-CoV-2 in children resolve faster than in adults without compromising adaptive immunity.
    Vono M; Huttner A; Lemeille S; Martinez-Murillo P; Meyer B; Baggio S; Sharma S; Thiriard A; Marchant A; Godeke GJ; Reusken C; Alvarez C; Perez-Rodriguez F; Eckerle I; Kaiser L; Loevy N; Eberhardt CS; Blanchard-Rohner G; Siegrist CA; Didierlaurent AM
    Cell Rep; 2021 Oct; 37(1):109773. PubMed ID: 34587479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kids' noses resist COVID-19.
    Zanoni I
    J Exp Med; 2024 Sep; 221(9):. PubMed ID: 38949639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolonged activation of nasal immune cell populations and development of tissue-resident SARS-CoV-2-specific CD8
    Roukens AHE; Pothast CR; König M; Huisman W; Dalebout T; Tak T; Azimi S; Kruize Y; Hagedoorn RS; Zlei M; Staal FJT; de Bie FJ; van Dongen JJM; Arbous SM; Zhang JLH; Verheij M; Prins C; van der Does AM; Hiemstra PS; de Vries JJC; Janse JJ; Roestenberg M; Myeni SK; Kikkert M; Yazdanbakhsh M; Heemskerk MHM; Smits HH; Jochems SP; ;
    Nat Immunol; 2022 Jan; 23(1):23-32. PubMed ID: 34937933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delayed Mucosal Antiviral Responses Despite Robust Peripheral Inflammation in Fatal COVID-19.
    Sidhu JK; Siggins MK; Liew F; Russell CD; Uruchurtu ASS; Davis C; Turtle L; Moore SC; Hardwick HE; Oosthuyzen W; Thomson EC; Semple MG; Baillie JK; Openshaw PJM; Thwaites RS;
    J Infect Dis; 2024 Jul; 230(1):e17-e29. PubMed ID: 39052740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Viral and host factors determine innate immune responses in airway epithelial cells from children with wheeze and atopy.
    Spann KM; Baturcam E; Schagen J; Jones C; Straub CP; Preston FM; Chen L; Phipps S; Sly PD; Fantino E
    Thorax; 2014 Oct; 69(10):918-25. PubMed ID: 24811725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamic innate immune response determines susceptibility to SARS-CoV-2 infection and early replication kinetics.
    Cheemarla NR; Watkins TA; Mihaylova VT; Wang B; Zhao D; Wang G; Landry ML; Foxman EF
    J Exp Med; 2021 Aug; 218(8):. PubMed ID: 34128960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergism and Antagonism of Bacterial-Viral Coinfection in the Upper Respiratory Tract.
    Manna S; McAuley J; Jacobson J; Nguyen CD; Ullah MA; Sebina I; Williamson V; Mulholland EK; Wijburg O; Phipps S; Satzke C
    mSphere; 2022 Feb; 7(1):e0098421. PubMed ID: 35044807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptome of nasopharyngeal samples from COVID-19 patients and a comparative analysis with other SARS-CoV-2 infection models reveal disparate host responses against SARS-CoV-2.
    Islam ABMMK; Khan MA; Ahmed R; Hossain MS; Kabir SMT; Islam MS; Siddiki AMAMZ
    J Transl Med; 2021 Jan; 19(1):32. PubMed ID: 33413422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.